A NATURAL GLYCOPROTEIN INHIBITOR (NIF) OF CD11B/CD18 REDUCES LEUKOCYTE ADHESION IN THE LIVER AFTER HEMORRHAGIC-SHOCK

被引:22
作者
BAUER, C
SIAPLAOURAS, S
SOULE, HR
MOYLE, M
MARZI, I
机构
[1] UNIV SAARLAND, SCH MED, DEPT TRAUMA SURG, D-66421 HOMBURG, GERMANY
[2] UNIV SAARLAND, SCH MED, DEPT ANESTHESIOL & CRIT CARE MED, D-66421 HOMBURG, GERMANY
[3] CORVAS INT INC, SAN DIEGO, CA 92121 USA
来源
SHOCK | 1995年 / 4卷 / 03期
关键词
D O I
10.1097/00024382-199509000-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study was designed to assess the effect of neutrophil inhibitory factor (NIF), a novel specific inhibitor of CD11b/CD18 on hepatic leukocyte trafficking by intravital microscopy 5 h after hemorrhagic shock. Anesthetized rats were instrumented for invasive hemodynamical monitoring. Hemorrhagic shock was induced for 60 min by withdrawal of arterial blood (mean arterial blood pressure = 40 mmHg). Rats were adequately resuscitated for 5 h to achieve a mean arterial blood pressure > 100 mmHg and were randomly assigned to blinded treatment with NIF or placebo control protein administered as a single intravenous bolus (10 mg/kg) at the time of resuscitation. Intrahepatic leukocyte adhesion was evaluated by in vivo fluorescence microscopy. There were no significant differences observed in hemodynamic parameters between the shock groups throughout the study, however, NIF significantly reduced firm leukocyte adhesion in liver sinusoids. The results suggest that NIF may be beneficial in the attenuation of the pathological shock-induced leukocyte adhesion.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 33 条
  • [1] INTERLEUKIN-1 RECEPTOR ANTAGONIST ATTENUATES LEUKOCYTE-ENDOTHELIAL INTERACTIONS IN THE LIVER AFTER HEMORRHAGIC-SHOCK IN THE RAT
    BAUER, C
    MARZI, I
    BAUER, M
    FELLGER, H
    LARSEN, R
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (06) : 1099 - 1105
  • [2] INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES
    BEVILACQUA, MP
    POBER, JS
    WHEELER, ME
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 2003 - 2011
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] CARLOS TM, 1994, BLOOD, V84, P2068
  • [5] FAN ST, 1993, J IMMUNOL, V150, P2972
  • [6] FERGUSON D, 1993, INT J MICROCIRC, V12, P45
  • [7] A POSSIBLE MECHANISM FOR VASCULAR ENDOTHELIAL-CELL INJURY ELICITED BY ACTIVATED LEUKOCYTES - A SIGNIFICANT INVOLVEMENT OF ADHESION MOLECULES, CD11/CD18, AND ICAM-1
    FUJITA, H
    MORITA, I
    MUROTA, SI
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 309 (01) : 62 - 69
  • [8] EFFECT OF A PLATELET ACTIVATING FACTOR ANTAGONIST (CV6209) ON SHOCK CAUSED BY TEMPORARY HEPATIC INFLOW OCCLUSION
    FUKUOKA, T
    NAKAJIMA, Y
    MATSUMOTO, M
    SEGAWA, M
    KANEHIRO, H
    HISANAGA, M
    WADA, T
    NAKANO, H
    [J]. LIFE SCIENCES, 1990, 47 (06) : 565 - 570
  • [9] FURIE MB, 1989, J IMMUNOL, V143, P3309
  • [10] GOLDMAN G, 1992, SURGERY, V111, P287